Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wiete Westerhof

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Archives of Dermatology|February 18, 2004
Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosisWiete Westerhof, Germaine N Relyveld, Melanie M Kingswijk, et al.
Photodermatology, Photoimmunology & Photomedicine|November 13, 2008
Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative studyTag S Anbar, Wiete Westerhof, Amal T Abdel-Rahman, et al.
Journal of the American Academy of Dermatology|October 21, 2006
Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized studyGermaine N Relyveld, Melanie M Kingswijk, Johannes B Reitsma, et al.
Pigment Cell Research|May 14, 2004
Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association studyHannah C de Vijlder, Wiete Westerhof, Geziena M Th Schreuder, et al.
The Journal of Pathology|December 19, 2001
Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformationClifton B Meije, Theodorus B M Hakvoort, Guido W M Swart, et al.
Experimental Dermatology|June 26, 2003
Increased epidermal functioning wild-type p53 expression in vitiligoKarin U Schallreuter, Stefanie Behrens-Williams, Tahira P Khaliq, et al.
Indian Journal of Dermatology, Venereology and Leprology|December 27, 2011
The effect of H₁ and H₂ receptor antagonists on melanogenesisTag S Anbar, Wiete Westerhof, Nafisa A Badawy, et al.
Pigment Cell & Melanoma Research|January 30, 2016
Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skinJared Klarquist, Jonathan M Eby, Steven W Henning, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 15, 2003
Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligoAnna Wańkowicz-Kalińska, René M J G J van den Wijngaard, Bert J Tigges, et al.
Pigment Cell & Melanoma Research|February 18, 2011
Koebner's phenomenon in vitiligo: European position paperNanja van Geel, Reinhart Speeckaert, Alain Taieb, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Archives of Dermatology|February 18, 2004
Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosisWiete Westerhof, Germaine N Relyveld, Melanie M Kingswijk, et al.
Photodermatology, Photoimmunology & Photomedicine|November 13, 2008
Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative studyTag S Anbar, Wiete Westerhof, Amal T Abdel-Rahman, et al.
Journal of the American Academy of Dermatology|October 21, 2006
Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized studyGermaine N Relyveld, Melanie M Kingswijk, Johannes B Reitsma, et al.
Pigment Cell Research|May 14, 2004
Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association studyHannah C de Vijlder, Wiete Westerhof, Geziena M Th Schreuder, et al.
The Journal of Pathology|December 19, 2001
Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformationClifton B Meije, Theodorus B M Hakvoort, Guido W M Swart, et al.
Experimental Dermatology|June 26, 2003
Increased epidermal functioning wild-type p53 expression in vitiligoKarin U Schallreuter, Stefanie Behrens-Williams, Tahira P Khaliq, et al.
Indian Journal of Dermatology, Venereology and Leprology|December 27, 2011
The effect of H₁ and H₂ receptor antagonists on melanogenesisTag S Anbar, Wiete Westerhof, Nafisa A Badawy, et al.
Pigment Cell & Melanoma Research|January 30, 2016
Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skinJared Klarquist, Jonathan M Eby, Steven W Henning, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 15, 2003
Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligoAnna Wańkowicz-Kalińska, René M J G J van den Wijngaard, Bert J Tigges, et al.
Pigment Cell & Melanoma Research|February 18, 2011
Koebner's phenomenon in vitiligo: European position paperNanja van Geel, Reinhart Speeckaert, Alain Taieb, et al.
Pageof 2